Monopar Therapeutics Inc. Share Price
NASDAQ: MNPRMonopar Therapeutics Inc. Stock Performance
Open $111.82 | Prev. Close $114.82 | Circuit Range N/A |
Day Range $109.14 - $113.61 | Year Range $33.87 - $123.95 | Volume 8,365 |
Average Traded $111.20 |
Monopar Therapeutics Inc. Share Price Today
As of 29 August 2026, Monopar Therapeutics Inc.'s share price is $112.24. The stock opened at $111.82, compared to its previous close of $114.82. During today's trading session, Monopar Therapeutics Inc.'s share price traded between $109.14 and $113.61, with an average price of $111.37. Over the past 52 weeks, the stock has recorded a high of $123.95 and a low of $33.87. In terms of performance, Monopar Therapeutics Inc.'s share price has risen by 104.57% over the last six months and is up 229.54% on a year-on-year basis.
Monopar Therapeutics Inc. Share Price Chart
Monopar Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) N/A | Revenue (TTM) N/A | Return On Equity (TTM) N/A |
Profit Margin N/A | Debt to Equity N/A | Quarterly Earnings Growth YoY -163.56% |
Monopar Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Monopar Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Monopar Therapeutics Inc.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Monopar Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $107.40 | $114.82 | +6.10% |
Jul 2026 | $95.57 | $108.22 | +17.05% |
Jun 2026 | $65.00 | $92.46 | +42.80% |
May 2026 | $51.35 | $64.75 | +22.84% |
Apr 2026 | $56.07 | $52.71 | -4.16% |
Mar 2026 | $53.38 | $55.00 | +0.25% |
Feb 2026 | $62.62 | $54.87 | -9.77% |
Jan 2026 | $66.06 | $60.80 | -6.57% |
Dec 2025 | $82.99 | $65.08 | -24.01% |
Nov 2025 | $80.51 | $85.65 | -0.06% |
Oct 2025 | $83.00 | $85.70 | +6.27% |
Sep 2025 | $36.33 | $80.64 | +136.76% |
MNPR Share Price FAQs
What is Monopar Therapeutics Inc. share price today?
What is the 52 week high and 52 week low of Monopar Therapeutics Inc. stock?
What is MNPR's net income for the last quarter?
What is the 5 year returns of MNPR?
What is the high & low stock price of MNPR today?
Can I buy MNPR shares in India?